Study Reveals How Inherited Genes Help Shape the Course of Cancer
 | Newswise

Study Reveals How Inherited Genes Help Shape the Course of Cancer | Newswise

Newswise — New York, NY [April 14, 2025]—A new multicenter study by researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with the National Cancer Institute-funded Clinical Proteomic Tumor Analysis Consortium (CPTAC) and colleagues around the world, has discovered that the genes we are born with—known as germline genetic variants—play a powerful,…

Read More
Post-Transfusion Activation of Coagulation Pathways During Severe COVID-19 Correlates with COVID-19 Convalescent Plasma Antibody Profiles | Newswise

Post-Transfusion Activation of Coagulation Pathways During Severe COVID-19 Correlates with COVID-19 Convalescent Plasma Antibody Profiles | Newswise

Abstract/summary: Newswise — Early antibody therapy can prevent severe SARS-CoV-2 infection (COVID-19). However, the effectiveness of COVID-19 convalescent plasma (CCP) therapy in treating severe COVID-19 remains inconclusive. To test a hypothesis that some CCP units are associated with a coagulopathy hazard in severe disease that offsets its benefits, we tracked 304 CCP units administered to…

Read More
New Lipid Nanoparticle Platform Delivers mRNA to the Brain Through the Blood-Brain Barrier | Newswise

New Lipid Nanoparticle Platform Delivers mRNA to the Brain Through the Blood-Brain Barrier | Newswise

Newswise — New York, NY [February 17, 2025]—Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature of the blood-brain barrier. The findings, in mouse models…

Read More
A Diabetes, Heart Failure, and Kidney Disease Medication is the First of Its Kind to Significantly Reduce Both Heart Attacks and Strokes | Newswise

A Diabetes, Heart Failure, and Kidney Disease Medication is the First of Its Kind to Significantly Reduce Both Heart Attacks and Strokes | Newswise

EMBARGOED UNTIL FEBRUARY 14, 2025 6:30PM EST                 Contact:  Ilana Nikravesh                 Mount Sinai Press Office                  212-241-9200                    [email protected] A Diabetes, Heart Failure, and Kidney Disease Medication is the First of Its Kind to…

Read More
Mount Sinai Opens the Hamilton and Amabel James Center for Artificial Intelligence and Human Health to Transform Health Care by Spearheading the AI Revolution | Newswise

Mount Sinai Opens the Hamilton and Amabel James Center for Artificial Intelligence and Human Health to Transform Health Care by Spearheading the AI Revolution | Newswise

Newswise — New York, NY [November 25, 2024]—Today, the Mount Sinai Health System, one of New York City’s largest academic medical systems, announced the opening of the Hamilton and Amabel James Center for Artificial Intelligence and Human Health, which is dedicated to enhancing health care delivery through the research, development, and application of innovative artificial…

Read More
Post-Transfusion Activation of Coagulation Pathways During Severe COVID-19 Correlates with COVID-19 Convalescent Plasma Antibody Profiles | Newswise

Mount Sinai International to Address African Healt | Newswise

Mount Sinai International (MSI), a part of the Mount Sinai Health System in New York that focuses on advancing health care across the world, will participate in the International Health Ministerial Summit in Kigali, Rwanda, on Wednesday and Thursday, December 4-5.   MSI’s President, Szabi Dorotovics, MD, MBA, and Executive Director, Saul Gitlin, will discuss strategies for identifying and developing global hospital-to-hospital collaborations and…

Read More